checkAd
    Startseite > Aktien > Larimar Therapeutics > Nachrichten
    Larimar Therapeutics Aktie
    6,8000
     
    EUR
    -0,73 %
    -0,0500 EUR
    Letzter Kurs 17.05.24 Tradegate
    6,6500
     
    EUR
    227 STK
    Geldkurs 08:00:20
    6,9500
     
    EUR
    216 STK
    Briefkurs 08:00:20
    ISIN: US5171251003 · WKN: A2P5PP · SYM: ZA71 · USA

    Neueste Nachrichten

    Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
    09.05.24 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
    14.03.24 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia
    11.03.24 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
    06.03.24 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
    16.02.24 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
    14.02.24 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics Announces Proposed Underwritten Public Offering
    13.02.24 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics Reports Positive Top-line Data from Phase 2 Dose Exploration Study from 25 mg and 50 mg Cohorts of Nomlabofusp in Patients with Friedreich’s Ataxia
    12.02.24 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
    14.11.23 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics Appoints Dr. Jeffery W. Sherman to its Board of Directors
    03.10.23 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics to Present at the Citi 18th Annual BioPharma Conference
    31.08.23 · globenewswire · Larimar Therapeutics
    Larimar Therapeutics Reports Second Quarter 2023 Operating and Financial Results
    10.08.23 · globenewswire · Larimar Therapeutics